MYC and squamous cell carcinoma: Remarkably, the PNDD-H1-fusion protein displayed 3 orders of magnitude greater potency than smaller CPP-H1-conjugates (cadherin, penetratin or TAT) in a c-Myc reporter assay in epidermoid carcinoma A431 cells, where high levels of c-Myc are present.